Skip to main content
. 2021 Mar 1;17(4):957–971. doi: 10.7150/ijbs.52591

Table 4.

PAR-2 expression in gastric carcinoma

Groups Cases (n) PAR-2 (n) PAR-2 positive rate (%)
Negative (-) Weakly positive (+) Moderately positive (++) Strongly positive (+++)
NGM 59 46 6 5 2 22.03
GWDAC 8 2 1 3 2 75.00*
GMDAC 29 3 4 5 17 89.66*
GPDAC 104 6 13 27 58 94.23*
LMGAC 53 3 4 12 34 94.34*

NGM, normal gastric mucosa; GWDAC, well-differentiated gastric adenocarcinoma; GMDAC, moderately differentiated gastric adenocarcinoma; GPDAC, poorly differentiated gastric adenocarcinoma; LMGAC, lymph node metastasis adenocarcinoma. *Compared with normal gastric mucosa, P=0.0418.